SCHEMBL5285059

SCHEMBL5285059

CCCOC(=O)/C=C/C(=O)OCC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 5/20 0.72
ATM Q13315 1/20 0.64
MAPT P10636 5/20 0.47
NPSR1 Q6W5P4 2/20 0.47
RAB9A P51151 1/20 0.47
APP P05067 1/20 0.46
ALOX5 P09917 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.42
MDM2 Q00987 1/20 0.42
ALDH1A1 P00352 2/20 0.42
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5285060 1.00 HCAR2 (0.72) HCAR2ATMMAPTNPSR1RAB9A
SCHEMBL5287207 1.00 HCAR2 (0.72) HCAR2ATMMAPTNPSR1RAB9A
Diethyl Maleate SCHEMBL9642988 1.00 HCAR2 (0.72) HCAR2ATMMAPTNPSR1RAB9A
SCHEMBL322228 0.93 HCAR2 (0.82) HCAR2ATMMAPTNPSR1RAB9A
SCHEMBL448456 0.93 HCAR2 (0.82) HCAR2ATMMAPTNPSR1RAB9A
SCHEMBL448454 0.93 HCAR2 (0.82) HCAR2ATMMAPTNPSR1RAB9A
Propyl Fumarate SCHEMBL18546478 0.92 HCAR2 (0.88) HCAR2ATMMAPTNPSR1RAB9A
Propyl Fumarate SCHEMBL18546477 0.92 HCAR2 (0.88) HCAR2ATMMAPTNPSR1RAB9A
SCHEMBL4934756 0.90 HCAR2 (0.78) HCAR2ATMMAPTNPSR1RAB9A
Hydrochloric Acid SCHEMBL28061109 0.90 HCAR2 (0.78) HCAR2ATMMAPTNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208135-B1 IN-SITU PREPARATION OF POLYASPARTIC ESTER MIXTURE BAYER AG (US) 2003-10-01 EP claimed
US-12152161-B2 Polyurea compositions from polyaspartic esters and secondary heterocyclic amines derived aspartic esters EVONIK OPERATIONS GMBH (DE) 2024-11-26 US disclosed
US-20240376343-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND 2-SUBSTITUTED BUTANEDIOIC ACID ESTERS EVONIK OPERATIONS GMBH (DE) 2024-11-14 US disclosed
EP-4388053-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND 2-SUBSTITUTED BUTANEDIOIC ACID ESTERS Evonik Operations GmbH (DE) 2024-06-26 EP disclosed
WO-2023020755-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND 2-SUBSTITUTED BUTANEDIOIC ACID ESTERS EVONIK OPERATIONS GMBH (DE) 2023-02-23 WO disclosed
US-20210147708-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND SECONDARY HETEROCYCLIC AMINES DERIVED ASPARTIC ESTERS EVONIK OPERATIONS GMBH (DE) 2021-05-20 US disclosed
EP-3788089-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND SECONDARY HETEROCYCLIC AMINES DERIVED ASPARTIC ESTERS Evonik Operations GmbH (DE) 2021-03-10 EP disclosed
US-9879153-B2 Anti-icing composite WANG LIANG (US) 2018-01-30 US disclosed
US-20170304253-A1 Laquinimod Combination Therapy For Treatment Of Multiple Sclerosis TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2017-10-26 US disclosed
US-9670304-B2 Composite for preventing ice adhesion WANG LIANG (US) 2017-06-06 US disclosed
US-6455224-B1 SUPPORT WITH HYDROPHILIC SURFACE AND PHOTOSENSITIVE LAYER CONTAINING INFRARED ABSORBENT WHICH CHANGES FROM HYDROPHILIC TO HYDROPHOBIC BY HEAT AND HYDROPHILIC POLYMER HAVING FUNCTIONAL GROUP RENDERING LAYER WATER DEVELOPABLE FUJI PHOTO FILM CO., LTD. (JP) 2002-09-24 US disclosed
EP-1165488-A1 PROCESS FOR THE PREPARATION OF POLYAMINO SUCCINIC ACIDS AND DERIVATIVES THEREOF THE DOW CHEMICAL COMPANY (US) 2002-01-02 EP disclosed
EP-1048457-A2 Lithographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2000-11-02 EP disclosed
WO-2000058263-A1 PROCESS FOR THE PREPARATION OF POLYAMINO SUCCINIC ACIDS AND DERIVATIVES THEREOF THE DOW CHEMICAL COMPANY (US) 2000-10-05 WO disclosed
EP-1031414-A1 Lithographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2000-08-30 EP disclosed
US-4924001-A Process for preparing 5-cyano-4, 5-dihydro-3,4-dicarboxypyrazole derivatives ELI LILLY AND COMPANY (US) 1990-05-08 US disclosed
US-4892956-A 5-cyano-4,5-dihydro-3,4-dicarboxypyrazole derivatives ELI LILLY AND COMPANY (US) 1990-01-09 US disclosed
US-4588776-A OLEFIN-UNSATURATED ACID DIESTER-/METH/ACRYLONITRILE TERPOLYMER MONSANTO COMPANY (US) 1986-05-13 US disclosed
US-4547428-A OLEFIN, DIESTER, SOLUBILIZING MONOMER MONSANTO COMPANY (US) 1985-10-15 US disclosed
EP-0119979-A2 Terpolymers useful as processing aids for vinyl halide polymers Monsanto Company (US) 1984-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170304253-A1 Laquinimod Combination Therapy For Treatment Of Multiple Sclerosis TLR7, IRF3, TLR5 HCAR2 138/4885ATM 2358/4885MAPT 2347/4885
US-20240376343-A1 POLYUREA COMPOSITIONS FROM POLYASPARTIC ESTERS AND 2-SUBSTITUTED BUTANEDIOIC ACID ESTERS BCKDK, PKD1, DERA HCAR2 830/4885ATM 1969/4885MAPT 1517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.